The Role Of Mitochondrial Fusion Protein 2 In Regulating ER Stress In Premature Placental Aging: A Case-Control Study

Aging Pathway
Therapeutic
Reduced levels of mitochondrial fusion protein 2 (Mfn2) in placentas from pregnancies with advanced maternal age contribute to premature placental aging by worsening endoplasmic reticulum (ER) stress.
Author

Gemini

Published

August 25, 2026

As women age, there’s an increased risk of complications during pregnancy, often linked to the placenta aging prematurely. Our cells contain tiny powerhouses called mitochondria, and a protein known as mitochondrial fusion protein 2 (Mfn2) plays a crucial role in keeping them healthy. This protein is already known to be important in various age-related conditions.

This research explored how Mfn2 behaves in placentas from older mothers and its connection to a cellular imbalance called endoplasmic reticulum (ER) stress. ER stress occurs when the cell’s protein-making machinery is overwhelmed, leading to a buildup of misfolded proteins.

The study found that in placentas from pregnancies with advanced maternal age, the levels of Mfn2 were significantly lower. This decrease in Mfn2 was shown to worsen placental aging by disrupting the cell’s ability to manage ER stress through a specific communication pathway called PERK. Essentially, Mfn2 helps to bind and calm down the PERK pathway, which in turn reduces harmful oxidative stress—an imbalance between damaging free radicals and protective antioxidants in the body—and slows down the aging process of placental cells.

These findings suggest that maintaining healthy levels of this protein could offer a new way to address premature placental aging and its associated pregnancy complications.


Source: link to paper